FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 348:2262-2263 May 29, 2003 Number 22 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Paasche-Orlow, M. K. PubMed Citation

To the Editor: Paasche-Orlow and colleagues report on the readability of informed-consent forms (Feb. 20 issue).¹ An important and interesting problem that we are now encountering is that sponsoring companies approach informed-consent documents as legal tools. Thus, when our institutional review board (IRB) has made recommendations for simplifying or clarifying language, the board has been told by sponsors that this cannot be done. For example, we recently received a letter fro m a company stating, "The language revised per the IRB concerning Privacy and Confidentiality is protected template language and may not be revised or altered in any way. If . . . [Full Text of this Article]

This article has been cited by other articles:

• Gilman, R. H., Garcia, H. H. (2004). Ethics review procedures for research in developing countries: a basic presumption of guilt. CMAJ 171: 248-249 [Full Text]